IBRN (IBRN) Stock Price & Analysis
IBRN (IBRN) fell 0.20% to USD 37.69 as of July 26, 2026 at 16:47 UTC, according to Nexqual real-time market data.
IBRN last closed at USD 37.77; the session ranged USD 37.66–37.82 on volume of 708 shares. Market capitalization is —, with a 52-week range of USD 22.95–40.42 (PCX). Source: Nexqual, July 26, 2026 at 16:47 UTC.
Key Statistics (as of July 26, 2026 at 16:47 UTC)
| Price | USD 37.69 |
|---|---|
| Change | ▼ 0.20% (down) |
| Previous Close | USD 37.77 |
| Open | USD 37.82 |
| Day Range | USD 37.66 – 37.82 |
| 52-Week Range | USD 22.95 – 40.42 |
| Volume | 708 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IBRN)
Nexqual's technical model rates IBRN "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 26, 2026 at 16:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.38 (neutral) |
| vs SMA50 | Above (USD 36.46) |
| MACD | 0.28 (positive) |
Financial Health Score (IBRN)
Nexqual rates IBRN's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 16:47 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BMED | iShares Health Innovation Activ | USD 30.73 | ▲ 1.72% |
| EFRA | iShares Environmental Infrastru | USD 35.73 | ▲ 0.79% |
| FTXH | First Trust Nasdaq Pharmaceutic | USD 38.97 | ▲ 1.69% |
| IBLC | iShares Blockchain and Tech ETF | USD 44.27 | ▼ 4.79% |
| IBBQ | Invesco Nasdaq Biotechnology ET | USD 32.28 | ▲ 0.26% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 16:47 UTC. This page is informational and not investment advice.